nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)
|
Fumoleau, Pierre |
|
2014 |
23 |
5 |
p. 663-669 7 p. |
artikel |
2 |
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial
|
Llombart-Cussac, Antonio |
|
2014 |
23 |
5 |
p. 656-662 7 p. |
artikel |
3 |
Assessing and managing breast cancer risk: Clinicians' current practice and future needs
|
Collins, Ian M. |
|
2014 |
23 |
5 |
p. 644-650 7 p. |
artikel |
4 |
Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup
|
Rordorf, Tamara |
|
2014 |
23 |
5 |
p. 511-525 15 p. |
artikel |
5 |
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients
|
Berghoff, Anna S. |
|
2014 |
23 |
5 |
p. 637-643 7 p. |
artikel |
6 |
Core communication components along the cancer care process: The perspective of breast cancer patients
|
Prades, Joan |
|
2014 |
23 |
5 |
p. 617-622 6 p. |
artikel |
7 |
Current and future role of neoadjuvant therapy for breast cancer
|
Untch, Michael |
|
2014 |
23 |
5 |
p. 526-537 12 p. |
artikel |
8 |
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
|
Cardoso, F. |
|
2014 |
23 |
5 |
p. 489-502 14 p. |
artikel |
9 |
Excision alone for small size ductal carcinoma in situ of the breast
|
Kim, Haeyoung |
|
2014 |
23 |
5 |
p. 586-590 5 p. |
artikel |
10 |
Genomic profiling of inflammatory breast cancer: A review
|
Bertucci, François |
|
2014 |
23 |
5 |
p. 538-545 8 p. |
artikel |
11 |
Impact of trastuzumab treatment beyond disease progression for advanced/metastatic breast cancer on survival – Results from a prospective, observational study in Germany
|
Jackisch, C. |
|
2014 |
23 |
5 |
p. 603-608 6 p. |
artikel |
12 |
Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya
|
Sayed, Shahin |
|
2014 |
23 |
5 |
p. 591-596 6 p. |
artikel |
13 |
Letter to the Editor
|
Kääriäinen, Minna |
|
2014 |
23 |
5 |
p. 691- 1 p. |
artikel |
14 |
Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: A large cohort study from clinical practice
|
Bonifazi, Martina |
|
2014 |
23 |
5 |
p. 573-578 6 p. |
artikel |
15 |
Low grade Ductal Carcinoma in situ (DCIS): How best to describe it?
|
Fallowfield, Lesley |
|
2014 |
23 |
5 |
p. 693-696 4 p. |
artikel |
16 |
Metastatic breast cancer subtypes and central nervous system metastases
|
Aversa, C. |
|
2014 |
23 |
5 |
p. 623-628 6 p. |
artikel |
17 |
One-step nucleic acid amplification assay for intraoperative prediction of non-sentinel lymph node metastasis in breast cancer patients with sentinel lymph node metastasis
|
Teramoto, Atsuko |
|
2014 |
23 |
5 |
p. 579-585 7 p. |
artikel |
18 |
Outcomes of patients with lobular in situ neoplasia of the breast: The role of vacuum-assisted biopsy
|
Parkin, C.K.E. |
|
2014 |
23 |
5 |
p. 651-655 5 p. |
artikel |
19 |
Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy?
|
Kim, Jiyoung |
|
2014 |
23 |
5 |
p. 670-675 6 p. |
artikel |
20 |
Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
|
Montemurro, Filippo |
|
2014 |
23 |
5 |
p. 690-691 2 p. |
artikel |
21 |
Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer
|
Mathew, J. |
|
2014 |
23 |
5 |
p. 567-572 6 p. |
artikel |
22 |
Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis
|
Staley, H. |
|
2014 |
23 |
5 |
p. 546-551 6 p. |
artikel |
23 |
Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study
|
Nardone, Luigia |
|
2014 |
23 |
5 |
p. 597-602 6 p. |
artikel |
24 |
Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: A French sentinel node multicenter cohort study
|
Houvenaeghel, Gilles |
|
2014 |
23 |
5 |
p. 561-566 6 p. |
artikel |
25 |
Quality of life among a population-based cohort of older patients with breast cancer
|
Neuner, Joan M. |
|
2014 |
23 |
5 |
p. 609-616 8 p. |
artikel |
26 |
Response to Barranger E, Ihrai T, response to the article by Thill et al.: “The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope”. The Breast 2014, 23(2):175–9
|
Thill, Marc |
|
2014 |
23 |
5 |
p. 692- 1 p. |
artikel |
27 |
Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: A prospective controlled study
|
Aerts, L. |
|
2014 |
23 |
5 |
p. 629-636 8 p. |
artikel |
28 |
Smartphone breast applications – What's the evidence?
|
Mobasheri, Mohammad H. |
|
2014 |
23 |
5 |
p. 683-689 7 p. |
artikel |
29 |
Strategies for fertility preservation in young early breast cancer patients
|
Tomasi-Cont, Nicoletta |
|
2014 |
23 |
5 |
p. 503-510 8 p. |
artikel |
30 |
The significance of circulating tumour cells in breast cancer: A review
|
Castle, J. |
|
2014 |
23 |
5 |
p. 552-560 9 p. |
artikel |
31 |
Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: An analysis of 1655 patients
|
Chan, Arlene |
|
2014 |
23 |
5 |
p. 676-682 7 p. |
artikel |